RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,549,453 | +39.0% | 1,725,167 | 0.0% | 0.07% | +42.0% |
Q2 2023 | $28,448,004 | -20.9% | 1,725,167 | -14.4% | 0.05% | -36.7% |
Q1 2023 | $35,964,833 | -44.8% | 2,015,966 | -9.9% | 0.08% | -68.7% |
Q4 2022 | $65,178,190 | +56.0% | 2,238,262 | +31.3% | 0.25% | +86.7% |
Q3 2022 | $41,773,000 | +571.1% | 1,705,000 | +13.7% | 0.14% | +694.1% |
Q2 2022 | $6,225,000 | +756.3% | 1,500,000 | +5900.0% | 0.02% | +325.0% |
Q4 2017 | $727,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |